Detalles de la búsqueda
1.
Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.
Pediatr Blood Cancer
; 68(8): e29067, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33871892
2.
Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 26(5): 884-892, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31891815
3.
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.
Biol Blood Marrow Transplant
; 26(8): e177-e182, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438042
4.
The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children.
Biol Blood Marrow Transplant
; 22(8): 1460-1466, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27090960
5.
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Transplant Cell Ther
; 29(6): 346.e1-346.e10, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36924931
6.
Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia.
Transplant Cell Ther
; 28(12): 852-858, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36170959
7.
Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.
Transplant Cell Ther
; 28(6): 325.e1-325.e7, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35302009
8.
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.
Transplant Cell Ther
; 28(7): 409.e1-409.e10, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35447374
9.
A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies.
Transplant Cell Ther
; 27(10): 837.e1-837.e10, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224914
10.
Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease.
Transplant Cell Ther
; 27(8): 685.e1-685.e8, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33895405
11.
Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach.
Pharmacoeconomics
; 38(5): 515-526, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128725
12.
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Blood Adv
; 4(21): 5414-5424, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147337
13.
Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia.
JNCI Cancer Spectr
; 3(4): pkz048, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31750417
14.
Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity.
Blood Adv
; 2(16): 2095-2103, 2018 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30135184
15.
Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].
Transplant Cell Ther
; 28(10): 715-716, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36202526
Resultados
1 -
15
de 15
1
Próxima >
>>